https://www.otsuka-us.com/ 2025-04-11T08:10:06-04:00 daily 1 https://www.otsuka-us.com/who-we-are 2025-05-08T08:22:59-04:00 monthly 0.7 https://www.otsuka-us.com/collaborations 2024-10-15T08:54:16-04:00 monthly 0.7 https://www.otsuka-us.com/news 2025-12-02T11:18:12-05:00 monthly 0.7 https://www.otsuka-us.com/careers-our-culture 2025-07-11T06:51:20-04:00 monthly 0.7 https://www.otsuka-us.com/careers-join-otsuka 2025-09-08T03:01:48-04:00 monthly 0.7 https://www.otsuka-us.com/research 2025-11-06T05:14:26-05:00 monthly 0.7 https://www.otsuka-us.com/clinical-trials 2025-05-20T03:17:37-04:00 monthly 0.7 https://www.otsuka-us.com/products 2025-12-02T12:02:39-05:00 monthly 0.7 https://www.otsuka-us.com/professional-communities 2024-09-03T09:40:07-04:00 monthly 0.7 https://www.otsuka-us.com/patient-resources 2024-09-02T04:49:02-04:00 monthly 0.7 https://www.otsuka-us.com/brand-portal 2024-01-25T12:02:09-05:00 monthly 0.7 https://www.otsuka-us.com/social-impact 2026-01-14T09:59:28-05:00 monthly 0.7 https://www.otsuka-us.com/california-supply-chains-act 2026-01-15T13:25:11-05:00 weekly 0.5 https://www.otsuka-us.com/returned-goods 2026-01-05T08:44:32-05:00 weekly 0.5 https://www.otsuka-us.com/authorized-distributor-of-record 2025-01-27T07:05:02-05:00 weekly 0.5 https://www.otsuka-us.com/terms-and-conditions 2022-05-05T02:24:48-04:00 weekly 0.5 https://www.otsuka-us.com/privacy-policy 2026-01-09T14:54:05-05:00 weekly 0.5 https://www.otsuka-us.com/us-locations 2025-04-22T06:23:21-04:00 weekly 0.5 https://www.otsuka-us.com/leadership 2024-07-16T05:13:08-04:00 monthly 0.7 https://www.otsuka-us.com/nephrology-immunology 2025-05-08T08:23:48-04:00 monthly 0.7 https://www.otsuka-us.com/inclusion-belonging 2025-05-20T03:05:08-04:00 monthly 0.7 https://www.otsuka-us.com/sms-terms-conditions 2024-09-23T12:21:06-04:00 monthly 0.7 https://www.otsuka-us.com/perspectives 2025-12-11T09:34:19-05:00 monthly 0.7 https://www.otsuka-us.com/caregiver 2025-12-19T11:08:22-05:00 monthly 0.7 https://www.otsuka-us.com/family-resources 2025-05-12T09:59:49-04:00 monthly 0.7 https://www.otsuka-us.com/CNS 2025-10-29T13:15:32-04:00 monthly 0.7 https://www.otsuka-us.com/leadership/kabir-nath-ma-mba 2024-12-13T12:08:35-05:00 monthly 0.7 https://www.otsuka-us.com/leadership/karen-gally-jd 2024-12-13T12:04:05-05:00 monthly 0.7 https://www.otsuka-us.com/leadership/nick-kurahashi-ms 2024-12-13T11:58:57-05:00 monthly 0.7 https://www.otsuka-us.com/leadership/jennifer-mcgee-jd 2024-12-13T12:08:51-05:00 monthly 0.7 https://www.otsuka-us.com/leadership/kevin-henley-jd 2024-12-13T12:04:33-05:00 monthly 0.7 https://www.otsuka-us.com/leadership/tarek-rabah 2025-06-20T08:07:57-04:00 monthly 0.7 https://www.otsuka-us.com/leadership/steve-rosen 2025-01-08T11:04:54-05:00 monthly 0.7 https://www.otsuka-us.com/leadership/louis-allesandrine 2024-12-13T11:59:29-05:00 monthly 0.7 https://www.otsuka-us.com/leadership/debra-barrett 2025-06-19T06:45:31-04:00 monthly 0.7 https://www.otsuka-us.com/leadership/john-kraus-md-phd 2025-02-03T06:46:57-05:00 monthly 0.7 https://www.otsuka-us.com/leadership/mike-laranjo-cpa-ca 2024-12-13T12:06:02-05:00 monthly 0.7 https://www.otsuka-us.com/leadership/bret-paulson 2024-12-13T11:58:22-05:00 monthly 0.7 https://www.otsuka-us.com/leadership/mary-hobart 2025-01-24T09:51:21-05:00 monthly 0.7 https://www.otsuka-us.com/leadership/shobana-narayanan 2024-12-13T12:07:16-05:00 monthly 0.7 https://www.otsuka-us.com/leadership/carole-augustine 2025-01-24T09:53:27-05:00 monthly 0.7 https://www.otsuka-us.com/leadership/lina-floren-smith 2024-12-13T11:57:57-05:00 monthly 0.7 https://www.otsuka-us.com/news/connect-4-mental-healthtm-announces-2016-community-innovation-award-recipients 2025-04-28T10:13:07-04:00 monthly 0.7 https://www.otsuka-us.com/news/alzheimers-speech-tracking-technology-wins-first-prize-pitch-competition 2023-12-12T04:29:23-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-co-host-tech-pitch-competition-dementia-solutions 2023-12-12T04:29:48-05:00 monthly 0.7 https://www.otsuka-us.com/news/idalopirdine-granted-fast-track-designation-us-food-and-drug-administration-fda 2025-04-28T10:13:55-04:00 monthly 0.7 https://www.otsuka-us.com/news/twitter-feed-community-guidelines 2023-12-12T04:28:25-05:00 monthly 0.7 https://www.otsuka-us.com/discover/fda-issues-complete-response-letter-for-digital-medicine-new-drug-application 2023-12-12T02:59:39-05:00 monthly 0.7 https://www.otsuka-us.com/news/us-food-and-drug-administration-approves-updated-label-otsukas-breathtekr-ubt-h-pylori-kit 2025-04-29T09:56:10-04:00 monthly 0.7 https://www.otsuka-us.com/discover/fda-approves-labeling-update-for-sprycel-to-include-3yr-1st-line-and-5yr-2nd-line-efficacy-in-cml 2023-12-12T03:00:31-05:00 monthly 0.7 https://www.otsuka-us.com/news/us-food-and-drug-administrations-cardiovascular-and-renal-drugs-advisory-committee-recommends 2023-12-12T04:25:18-05:00 monthly 0.7 https://www.otsuka-us.com/news/ibm-and-otsuka-develop-transformative-care-coordination-solution 2023-12-12T04:25:41-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-acquires-rights-hematological-cancer-treatment-dacogenr-decitabine-eisai-us 2023-12-12T04:28:51-05:00 monthly 0.7 https://www.otsuka-us.com/discover/fda-accepts-for-review-snda-to-expand-abilify-maintena-labeling 2025-04-28T07:58:16-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-pharmaceutical-initiates-phase-3-clinical-trial-tolvaptan-patients-autosomal-dominant 2025-04-29T09:32:36-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-and-lundbeck-submit-new-drug-application-us-brexpiprazole-treatment-schizophrenia-and 2023-12-12T04:27:37-05:00 monthly 0.7 https://www.otsuka-us.com/news/us-fda-accepts-otsuka-and-lundbecks-filing-review-brexpiprazole-treatment-schizophrenia-and 2023-12-12T04:26:03-05:00 monthly 0.7 https://www.otsuka-us.com/discover/fda-approves-dual-chamber-syringe-for-abilify-maintena-for-the-treatment-of-schizophrenia 2025-04-28T09:46:13-04:00 monthly 0.7 https://www.otsuka-us.com/news/aripiprazole-once-monthly-injectable-shows-superior-effectiveness-paliperidone-palmitate-once 2025-05-07T03:10:00-04:00 monthly 0.7 https://www.otsuka-us.com/discover/fda-accepts-for-review-supplemental-nda-for-deltoid-administration-of-abilify-maintena-extended-release-injectable-suspension 2025-04-28T07:59:23-04:00 monthly 0.7 https://www.otsuka-us.com/news/results-phase-iii-study-brexpiprazole-adult-patients-schizophrenia-published-american-journal 2023-12-12T04:23:57-05:00 monthly 0.7 https://www.otsuka-us.com/discover/otsuka-lundbeck-to-present-data-on-brexpiprazole-in-schizophrenia-and-mdd-at-apa-annual-meeting 2025-04-28T09:58:32-04:00 monthly 0.7 https://www.otsuka-us.com/news/us-fda-approves-otsuka-and-lundbecks-rexultir-brexpiprazole-adjunctive-treatment-adults-major 2023-12-12T04:23:28-05:00 monthly 0.7 https://www.otsuka-us.com/discover/fda-approves-deltoid-injection-site-for-abilify-maintena-for-extended-release-injectable-suspension-in-the-treatment-of-schizophrenia 2025-04-28T09:44:29-04:00 monthly 0.7 https://www.otsuka-us.com/discover/fda-approves-labeling-update-for-sprycel-to-include-5yr-1st-line-and-7yr-2nd-line-efficacy-and-safety-data-in-cml 2025-04-28T09:47:27-04:00 monthly 0.7 https://www.otsuka-us.com/discover/fda-accepts-first-digital-medicine-new-drug-application-for-otsuka-and-proteus-digital-health 2023-12-12T03:11:12-05:00 monthly 0.7 https://www.otsuka-us.com/discover/fda-accepts-for-review-otsuka-lundbecks-snda-filing-for-labeling-update-of-rexulti-for-maintenance-treatment-of-schizophrenia 2025-05-07T03:08:58-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-us-pharmaceutical-affiliates-praise-establishment-mental-health-and-substance-use 2025-04-29T09:49:36-04:00 monthly 0.7 https://www.otsuka-us.com/news/us-fda-approves-labeling-update-rexultir-brexpiprazole-maintenance-treatment-schizophrenia 2025-04-29T09:55:38-04:00 monthly 0.7 https://www.otsuka-us.com/discover/ebony-magazine-bob-oliver-to-2016-power-100 2023-12-12T03:28:57-05:00 monthly 0.7 https://www.otsuka-us.com/discover/articles-961 2023-12-12T03:10:19-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-statement-supporting-us-house-reps-passage-21st-century-cures-mental-health-reform 2023-12-12T03:20:46-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-statement-supporting-us-senate-passage-21st-century-cures-mental-health-reform 2023-12-12T03:21:54-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-and-lundbeck-present-data-acnp-annual-meeting-long-acting-injectable-aripiprazole 2025-04-25T07:31:48-04:00 monthly 0.7 https://www.otsuka-us.com/discover/articles-985 2025-04-28T07:49:05-04:00 monthly 0.7 https://www.otsuka-us.com/discover/articles-1000 2025-04-28T07:03:36-04:00 monthly 0.7 https://www.otsuka-us.com/news/caring-mental-health-through-music-compassion-and-hope 2023-12-12T03:23:08-05:00 monthly 0.7 https://www.otsuka-us.com/discover/akebia-and-otsuka-expand-relationship 2025-05-07T03:03:31-04:00 monthly 0.7 https://www.otsuka-us.com/discover/articles-1023 2023-12-12T03:09:21-05:00 monthly 0.7 https://www.otsuka-us.com/discover/articles-1029 2025-05-07T03:05:03-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-and-teva-sign-licensing-agreement-japan-prophylactic-migraine-drug-candidate 2023-12-12T03:23:30-05:00 monthly 0.7 https://www.otsuka-us.com/discover/articles-1032 2025-05-07T03:06:20-04:00 monthly 0.7 https://www.otsuka-us.com/discover/articles-1033 2025-04-28T07:18:32-04:00 monthly 0.7 https://www.otsuka-us.com/discover/articles-1063 2023-12-12T03:05:40-05:00 monthly 0.7 https://www.otsuka-us.com/discover/articles-1069 2023-12-12T03:05:12-05:00 monthly 0.7 https://www.otsuka-us.com/discover/articles-1075 2025-04-28T07:30:55-04:00 monthly 0.7 https://www.otsuka-us.com/discover/articles-1080 2023-12-12T03:04:07-05:00 monthly 0.7 https://www.otsuka-us.com/discover/articles-1083 2023-12-12T03:37:56-05:00 monthly 0.7 https://www.otsuka-us.com/discover/articles-1085 2023-12-12T03:37:36-05:00 monthly 0.7 https://www.otsuka-us.com/discover/articles-1086 2023-12-12T03:37:05-05:00 monthly 0.7 https://www.otsuka-us.com/discover/articles-1087 2023-12-12T03:38:27-05:00 monthly 0.7 https://www.otsuka-us.com/discover/articles-1150 2023-12-12T03:38:47-05:00 monthly 0.7 https://www.otsuka-us.com/discover/articles-1156 2023-12-12T03:39:14-05:00 monthly 0.7 https://www.otsuka-us.com/discover/articles-1174 2023-12-12T03:39:35-05:00 monthly 0.7 https://www.otsuka-us.com/discover/articles-1188 2023-12-12T03:40:10-05:00 monthly 0.7 https://www.otsuka-us.com/news/usagainstalzheimers-launches-revolutionary-alzheimers-disease-patient-and-caregiver-engagement 2023-12-12T03:18:54-05:00 monthly 0.7 https://www.otsuka-us.com/discover/otsuka-lundbeck-phase-three-brexpiprazole-trial 2023-12-12T03:36:31-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-pharmaceutical-development-commercialization-inc-develops-relapse-risk-assessment 2023-12-12T03:18:31-05:00 monthly 0.7 https://www.otsuka-us.com/discover/articles-1206 2023-12-12T03:35:40-05:00 monthly 0.7 https://www.otsuka-us.com/discover/articles-1208 2025-04-28T07:48:09-04:00 monthly 0.7 https://www.otsuka-us.com/news/startup-health-raises-31m-novartis-ping-group-chiesi-group-guidewell-and-otsuka 2023-12-12T03:17:38-05:00 monthly 0.7 https://www.otsuka-us.com/discover/otsuka-and-proteus-announce-expanded-collaboration 2025-04-28T09:51:32-04:00 monthly 0.7 https://www.otsuka-us.com/discover/data-demonstrate-safety-and-efficacy-in-patients-with-schizophrenia 2025-05-07T03:07:55-04:00 monthly 0.7 https://www.otsuka-us.com/discover/opdc-hosts-roundtable-on-healthcare-and-technology-with-bonnie-watson-coleman 2023-12-12T03:33:01-05:00 monthly 0.7 https://www.otsuka-us.com/discover/otsuka-and-patrick-j-kennedy-lead-policy-forum-2018 2023-12-12T03:32:40-05:00 monthly 0.7 https://www.otsuka-us.com/discover/otsuka-and-click-therapeutics-collaborate 2025-04-28T09:49:41-04:00 monthly 0.7 https://www.otsuka-us.com/discover/otsuka-and-verily-form-strategic-alliance 2023-12-12T03:29:31-05:00 monthly 0.7 https://www.otsuka-us.com/discover/light-the-way-installation 2023-12-12T02:44:47-05:00 monthly 0.7 https://www.otsuka-us.com/news/uc-san-diego-center-microbiome-innovation-cmi-announces-otsuka-pharmaceutical-development 2023-12-12T03:20:02-05:00 monthly 0.7 https://www.otsuka-us.com/discover/2nd-national-forum-on-mental-health-policy 2025-04-28T06:59:09-04:00 monthly 0.7 https://www.otsuka-us.com/discover/otsuka-announces-retirement-of-dr-william-h-carson 2025-04-28T09:56:36-04:00 monthly 0.7 https://www.otsuka-us.com/discover/sozosei-foundation-donations-covid-19 2025-04-28T10:09:21-04:00 monthly 0.7 https://www.otsuka-us.com/discover/otsuka-provides-eligible-newly-uninsured-patients-with-no-cost-access-to-otsuka-medicines 2025-04-28T10:05:06-04:00 monthly 0.7 https://www.otsuka-us.com/discover/sozosei-foundation-supports-mental-health-and-kidney-diseases 2025-04-28T10:10:19-04:00 monthly 0.7 https://www.otsuka-us.com/discover/compass-series-b 2023-12-12T03:26:17-05:00 monthly 0.7 https://www.otsuka-us.com/discover/positive-top-line-results-from-global-phase-3-program-of-vadadustat 2023-12-12T03:19:32-05:00 monthly 0.7 https://www.otsuka-us.com/discover/well-beings-campaign-featuring-ken-burns-documentary-series 2025-04-28T10:11:19-04:00 monthly 0.7 https://www.otsuka-us.com/discover/otsuka-announces-positive-top-line-results-from-two-phase-3-studies-of-centanafadine 2025-04-28T09:55:21-04:00 monthly 0.7 https://www.otsuka-us.com/discover/otsuka-launches-nephu-dedicated-to-kidney-health 2025-04-28T09:57:32-04:00 monthly 0.7 https://www.otsuka-us.com/discover/proteus-assets-purchase 2025-04-28T10:06:08-04:00 monthly 0.7 https://www.otsuka-us.com/news/nih-public-private-partnership-advance-early-interventions-schizophrenia 2023-12-12T04:20:17-05:00 monthly 0.7 https://www.otsuka-us.com/discover/otsuka-earns-designation-as-a-great-place-to-work 2025-04-25T09:00:57-04:00 monthly 0.7 https://www.otsuka-us.com/news/sozosei-foundation-aims-set-new-course-decriminalizing-and-treating-mental-illness-america 2023-12-12T04:21:22-05:00 monthly 0.7 https://www.otsuka-us.com/discover/msrd-enters-collaboration-agreement-with-rugen 2025-04-28T09:48:47-04:00 monthly 0.7 https://www.otsuka-us.com/discover/otsuka-and-the-columbia-university-mailman-school-of-public-health-enter-into-a-global-pharmacovigilance-agreement 2025-04-28T09:52:38-04:00 monthly 0.7 https://www.otsuka-us.com/node/666 2023-12-12T03:44:18-05:00 monthly 0.7 https://www.otsuka-us.com/node/671 2023-12-12T04:19:21-05:00 monthly 0.7 https://www.otsuka-us.com/node/676 2025-04-29T09:56:49-04:00 monthly 0.7 https://www.otsuka-us.com/node/681 2023-12-12T03:44:41-05:00 monthly 0.7 https://www.otsuka-us.com/node/686 2023-12-12T03:43:57-05:00 monthly 0.7 https://www.otsuka-us.com/node/1286 2023-12-12T04:18:59-05:00 monthly 0.7 https://www.otsuka-us.com/node/1291 2023-12-12T04:18:39-05:00 monthly 0.7 https://www.otsuka-us.com/node/1681 2023-12-12T04:30:28-05:00 monthly 0.7 https://www.otsuka-us.com/news/akebia-and-otsuka-announce-fda-acceptance-filing-new-drug-application-vadadustat-treatment 2025-04-25T08:56:46-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-hosts-dr-nina-vasan-governor-charlie-baker-and-representative-jamie-raskin-third-annual 2023-12-12T03:45:33-05:00 monthly 0.7 https://www.otsuka-us.com/news/sozosei-foundation-awards-grants-decriminalize-mental-illness 2023-12-12T03:50:47-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-signs-three-year-collaboration-holmusk-enhance-digital-health-and-data-analytics-global 2025-04-29T10:52:03-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-awarded-grant-phase-2-trial-combining-novel-anti-tuberculosis-compound-opc-167832 2023-12-12T03:49:42-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-reports-topline-outcomes-phase-ii-trial-evaluated-brexpiprazole-treatment-borderline 2023-12-12T04:17:10-05:00 monthly 0.7 https://www.otsuka-us.com/news/mcquade-center-strategic-research-and-development-enters-collaboration-ache-develop-potential 2023-12-12T04:16:46-05:00 monthly 0.7 https://www.otsuka-us.com/news/mcquade-center-strategic-research-and-development-enters-agreement-sentinel-oncology-develop 2023-12-12T04:16:25-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-recognized-driving-greater-equality-women-workplace-healthcare-businesswomens 2023-12-12T04:15:42-05:00 monthly 0.7 https://www.otsuka-us.com/news/mcquade-center-strategic-research-and-development-launches-otsuka-digital-pioneer-initiative 2023-12-12T04:15:23-05:00 monthly 0.7 https://www.otsuka-us.com/news/sumitomo-dainippon-pharma-and-otsuka-announce-worldwide-collaboration-and-license-agreement 2023-12-12T04:31:20-05:00 monthly 0.7 https://www.otsuka-us.com/news/sunovion-sumitomo-dainippon-pharma-and-otsuka-enter-worldwide-development-and 2023-12-12T04:16:01-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-and-lundbeck-announce-fda-acceptance-supplemental-new-drug-application-receive-priority 2023-12-12T04:31:43-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-responds-office-inspector-generals-favorable-opinion-regarding-its-hospital-free-trial 2023-12-12T04:32:13-05:00 monthly 0.7 https://www.otsuka-us.com/news/mcquade-center-strategic-research-and-development-and-mindset-pharma-collaborate-develop 2023-12-12T04:32:37-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-and-lundbeck-announce-fda-approval-supplemental-new-drug-application-rexultir 2023-12-12T04:33:06-05:00 monthly 0.7 https://www.otsuka-us.com/news/donations-humanitarian-support-ukrainian-people-otsuka-holdings-and-otsuka-group-companies 2023-12-12T04:33:58-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-releases-inaugural-economic-health-impact-report 2023-12-12T02:57:14-05:00 monthly 0.7 https://www.otsuka-us.com/news/4th-annual-mental-health-policy-forum-convenes-national-policymakers-and-advocates-capitol 2023-12-12T02:48:34-05:00 monthly 0.7 https://www.otsuka-us.com/news/announcement-termination-global-license-agreements-renal-anemia-treatment-akebia-therapeutics 2023-12-12T02:49:51-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-pharmaceutical-and-lundbeck-announce-positive-results-showing-reduced-agitation 2023-12-12T04:07:58-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-recognized-best-place-work-disability-inclusion 2023-12-12T02:50:27-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-pharmaceutical-and-lundbeck-present-positive-results-showing-reduced-agitation-patients 2023-12-12T02:51:29-05:00 monthly 0.7 https://www.otsuka-us.com/news/treating-patients-smi-requires-objective-data-and-patient-buy 2023-12-12T02:51:06-05:00 monthly 0.7 https://www.otsuka-us.com/news/satcher-health-leadership-institute-morehouse-school-medicine-releases-first-ever-report 2023-12-12T03:12:34-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-and-lundbeck-announce-us-fda-acceptance-new-drug-application-aripiprazole-2-month-ready 2023-12-12T02:52:13-05:00 monthly 0.7 https://www.otsuka-us.com/news/avanir-pharmaceuticals-inc-business-will-be-integrated-otsuka-america-pharmaceutical-inc 2023-12-12T02:52:47-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-pharmaceutical-and-lundbeck-present-positive-data-multiple-phase-3-studies-showing 2025-04-25T09:25:19-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-and-sunovion-initiate-clinical-development-ulotaront-adjunctive-treatment-major 2025-04-25T09:05:14-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-and-lundbeck-announce-fda-acceptance-and-priority-review-snda-brexpiprazole-treatment 2025-04-25T09:02:47-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-and-verily-expand-collaboration-novel-clinical-trials-solutions-accelerate-research 2023-12-12T02:56:54-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-and-lundbeck-published-study-results-showing-aripiprazole-2-month-ready-use-long-acting 2025-04-25T08:53:37-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-and-lundbeck-issue-statement-us-food-and-drug-administration-fda-advisory-committee 2025-04-29T10:36:06-04:00 monthly 0.7 https://www.otsuka-us.com/news/sunovion-and-otsuka-initiate-clinical-development-ulotaront-treatment-generalized-anxiety 2025-04-29T09:54:16-04:00 monthly 0.7 https://www.otsuka-us.com/news/fda-approves-otsuka-and-lundbecks-abilify-asimtufiir-aripiprazole-first-once-every-two-months 2025-04-25T10:04:50-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-and-lundbeck-announce-us-food-and-drug-administration-fda-approval-supplemental-new 2025-04-29T10:03:24-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-earns-top-score-2023-disability-equality-index 2023-12-12T02:46:09-05:00 monthly 0.7 https://www.otsuka-us.com/news/sumitomo-pharma-and-otsuka-announce-topline-results-phase-3-diamond-1-and-diamond-2-clinical 2023-12-12T03:12:13-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-pharmaceutical-acquire-mindset-pharma-strengthens-pipeline-area-psychiatric-and 2023-12-12T04:14:30-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-pharmaceutical-and-lundbeck-announce-topline-results-two-phase-3-trials-brexpiprazole 2023-12-12T04:14:54-05:00 monthly 0.7 https://www.otsuka-us.com/news/new-england-journal-medicine-publishes-complete-results-positive-phase-2-trial-sibeprenlimab 2023-12-12T04:09:53-05:00 monthly 0.7 https://www.otsuka-us.com/news/olympic-gold-medalist-missy-franklin-collaborates-otsuka-raise-awareness-kidney-disease 2023-12-12T04:09:27-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-pharmaceutical-announces-positive-topline-results-two-pivotal-phase-3-trials 2023-12-12T04:09:05-05:00 monthly 0.7 https://www.otsuka-us.com/news/jama-neurology-publishes-complete-results-positive-phase-3-study-rexultir-brexpiprazole 2025-04-29T10:05:05-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-announces-corporate-commitment-value-mind-every-family-caregiver 2025-04-29T10:01:51-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-announces-phase-3-topline-results-avp-786-treatment-agitation-associated-dementia-due 2024-09-03T08:55:04-04:00 monthly 0.7 https://www.otsuka-us.com/news/sibeprenlimab-receives-us-fda-breakthrough-therapy-designation-treatment-immunoglobulin 2025-04-25T08:50:35-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsukas-economic-and-health-impact-report-20232024 2024-09-03T08:53:34-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-and-sumitomo-revise-license-agreement 2024-09-03T08:52:46-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-and-lundbeck-present-new-data-analyses-efficacy-rexultir-brexpiprazole-agitation 2024-09-03T08:51:52-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-announces-interim-data-phase-2bc-trial-indicating-new-investigational-compound-may 2025-04-25T09:17:22-04:00 monthly 0.7 https://www.otsuka-us.com/news/rejoyn-fda-authorized 2024-09-03T08:50:24-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-works-verily-launch-longitudinal-mental-health-registry-advance-novel-research 2025-04-29T09:50:17-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-and-lundbeck-submit-snda-fda-review-brexpiprazole-and-sertraline-combination-potential 2025-04-29T09:14:39-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-becomes-lead-founding-sponsor-pbs-and-wetas-new-caregiving-documentary 2025-04-29T10:02:23-04:00 monthly 0.7 https://www.otsuka-us.com/news/meharry-school-global-health-releases-landmark-report-showing-mental-health-inequities-us-0 2025-04-28T10:16:38-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-terminate-development-avp-786 2025-04-29T09:37:23-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-and-lundbeck-present-results-three-clinical-trials-brexpiprazole-combination-sertraline 2025-04-29T10:29:37-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-and-lundbeck-announce-fda-acceptance-snda-filing-brexpiprazole-combination-sertraline-0 2025-04-29T08:59:47-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-and-lundbeck-present-new-rexultir-brexpiprazole-post-hoc-efficacy-data-analyses 2025-04-29T09:05:15-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-pharmaceutical-acquire-jnana-therapeutics-inc 2024-09-23T08:44:54-04:00 monthly 0.7 https://www.otsuka-us.com/news/barbara-corcoran-announces-collaboration-otsuka-and-lundbeck-raise-awareness-agitation 2025-04-28T10:12:08-04:00 monthly 0.7 https://www.otsuka-us.com/news/mental-health-america-and-otsuka-collaborate-address-mental-health-inequities-new-jersey 2025-04-28T10:50:42-04:00 monthly 0.7 https://www.otsuka-us.com/news/new-study-finds-family-caregivers-would-earn-six-figures-if-paid-salary 2025-04-29T08:57:35-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-announces-positive-interim-results-phase-3-trial-sibeprenlimab-treatment-immunoglobulin 2025-04-29T09:25:18-04:00 monthly 0.7 https://www.otsuka-us.com/news/new-report-reveals-us-family-caregivers-perform-equivalent-staggering-8735-billion-worth-labor 2025-04-29T08:55:33-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-provides-update-sibeprenlimab-investigational-monoclonal-antibody-treatment-iga 2025-04-29T09:36:16-04:00 monthly 0.7 https://www.otsuka-us.com/news/jama-psychiatry-publishes-results-otsuka-and-lundbecks-phase-3-trial-brexpiprazole-combination 2025-04-28T10:15:34-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-announces-fda-plans-host-advisory-committee-meeting-discuss-snda-brexpiprazole 2025-04-28T04:23:51-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-files-biologics-license-application-bla-sibeprenlimab-treatment-immunoglobulin 2025-07-31T15:08:11-04:00 monthly 0.7 https://www.otsuka-us.com/news/new-report-shows-nearly-half-us-states-are-threshold-caregiving-emergency 2025-07-31T15:21:49-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-and-lundbeck-issue-statement-us-food-and-drug-administration-fda-advisory-committee-0 2025-07-18T19:05:07-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-sibeprenlimab-phase-3-data-show-statistically-significant-and-clinically-meaningful 2025-07-31T14:58:53-04:00 monthly 0.7 https://www.otsuka-us.com/news/pbs-and-weta-caregiving-documentary-executive-producer-bradley-cooper-now-available-stream 2025-07-31T15:39:52-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-announces-fda-acceptance-and-priority-review-biologics-license-application-bla 2025-07-31T15:44:59-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-and-lundbeck-receive-complete-response-letter-us-fda-snda-rexultir-brexpiprazole 2025-09-20T01:51:37-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-announces-first-participants-enrolled-phase-3-clinical-trial-evaluating-investigational 2025-11-25T15:04:07-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-pharmaceutical-submits-new-drug-application-us-fda-centanafadine-treatment-adhd 2025-11-25T15:13:12-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-receives-fda-accelerated-approval-voyxactr-sibeprenlimab-szsi-reduction-proteinuria 2025-12-01T07:57:49-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-and-mental-health-america-expand-support-new-jersey-communities-increase-access-mental 2025-12-02T11:09:10-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-initiates-global-phase-3-clinical-trial-evaluating-repinatrabit-treatment 2026-01-06T09:40:31-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-announces-fda-acceptance-and-priority-review-new-drug-application-centanafadine 2026-01-27T08:03:51-05:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-unveils-new-repinatrabit-open-label-extension-data-phenylketonuria-pku-signaling 2026-03-12T09:10:16-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-showcases-new-efficacy-and-safety-data-voyxactr-sibeprenlimab-szsi-patients-iga 2026-03-25T08:11:58-04:00 monthly 0.7 https://www.otsuka-us.com/news/otsuka-pharmaceutical-acquire-transcend-therapeutics-expands-otsuka-portfolio-psychiatric-and 2026-03-27T08:36:48-04:00 monthly 0.7